Albert J. Robichaud, Ph.D.
Albert J. Robichaud is a Partner at Cure Ventures. He previously served as Chief Scientific Officer at Sage Therapeutics and held leadership roles at several pharmaceutical companies.
What Albert can write
Career
- Bristol-Myers Squibb
- DuPont Pharmaceuticals Company
- Merck
- Wyeth Discovery Research · Director of Medicinal Chemistry
- Lundbeck Research, USA · Vice President of Chemical and Pharmacokinetic Sciences
- Sage Therapeutics · Chief Scientific Officer
- Cure Ventures · PartnerNow
Companies founded
Focus
Also at Cure Ventures
Partners like Albert
At firms with a similar stage, sector and check size.
Alert me when Cure Ventures is active
One email when Albert's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Albert J. Robichaud, Ph.D.?
Albert J. Robichaud is a Partner at Cure Ventures. He previously served as Chief Scientific Officer at Sage Therapeutics and held leadership roles at several pharmaceutical companies.
How much does Albert J. Robichaud, Ph.D. invest?
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
How do I pitch Albert J. Robichaud, Ph.D.?
Email [email protected], the firm's inbox for founders, and name Albert in the subject. A warm intro from a founder Cure Ventures backed works better.
What did Albert J. Robichaud, Ph.D. do before Cure Ventures?
Bristol-Myers Squibb; DuPont Pharmaceuticals Company; Merck; Director of Medicinal Chemistry at Wyeth Discovery Research; Vice President of Chemical and Pharmacokinetic Sciences at Lundbeck Research, USA; Chief Scientific Officer at Sage Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.